Arkolith/Insider Trading/NAUT/Form 4

Patel Sujal M

CEO, President, and Secretary, Director, 10% OwnerNautilus Biotechnology, Inc. (NAUT) · full profile →Form 4 · filed Mar 7, 2024
Net Buying
Open-Market Buys
$99K
Open-Market Sells
$0
Net Open-Market Flow
$99K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 7, 2024Buy(P)19K$2.89$54K10.1M
Mar 6, 2024Buy(P)9K$2.70$25K10.0M
Mar 5, 2024Buy(P)7K$2.65$20K10.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-24-009754) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML